Thus, regardless of leakage into the periphery, if there was indeed a greater contribution of the central AT1 receptors to hypertension in BPH/2J mice, we would see a greater hypotensive effect following ICV administration than following SC administration. The gene discussed is AGTR1; the disease is benign prostatic hyperplasia.